Design of the Wegener's Granulomatosis Etanercept Trial (WGET)
- 31 August 2002
- journal article
- clinical trial
- Published by Elsevier in Controlled Clinical Trials
- Vol. 23 (4), 450-468
- https://doi.org/10.1016/s0197-2456(02)00209-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosisArthritis & Rheumatism, 1997
- Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitidesArthritis & Rheumatism, 1997
- An analysis of forty‐two wegener's granulomatosis patients treated with methotrexate and prednisoneArthritis & Rheumatism, 1995
- Wegener Granulomatosis: An Analysis of 158 PatientsAnnals of Internal Medicine, 1992
- Covariate adjustment of treatment effects in clinical trialsControlled Clinical Trials, 1991
- The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosisArthritis & Rheumatism, 1990
- Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitisClinical and Experimental Immunology, 1990
- Tests of Hypotheses in Overdispersed Poisson Regression and Other Quasi-Likelihood ModelsJournal of the American Statistical Association, 1990
- The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infectionCell, 1989
- Giant-cell Granuloma of the Respiratory Tract (Wegener's Granulomatosis)BMJ, 1958